Coreceptor Reversal in the Thymus
Immunity, ISSN: 1074-7613, Vol: 13, Issue: 1, Page: 59-71
2000
- 221Citations
- 149Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations221
- Citation Indexes221
- 221
- CrossRef206
- Captures149
- Readers149
- 136
- 13
Article Description
A central paradigm of T cell development is that CD4 + 8 + (DP) thymocytes differentiate into CD4 + or CD8 + T cells in response to intrathymic signals that extinguish transcription of the inappropriate coreceptor molecule. Contrary to this prevailing paradigm, we now demonstrate that signaled DP thymocytes initially terminate CD8 transcription even when differentiating into CD8 + T cells. Remarkably, thymocytes that have selectively terminated CD8 transcription can be signaled by IL-7 to differentiate into CD8 + T cells by silencing CD4 transcription and reinitiating CD8 transcription, events we refer to as “coreceptor reversal.” These observations significantly alter our understanding of CD8 + T cell differentiation and lead to a new perspective (“kinetic signaling”) on CD4/CD8 lineage determination in the thymus. These observations also suggest a novel mechanism by which bipotential cells throughout development can determine their appropriate cell fate.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S107476130000008X; http://dx.doi.org/10.1016/s1074-7613(00)00008-x; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0033696599&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/10933395; http://linkinghub.elsevier.com/retrieve/pii/S107476130000008X; http://api.elsevier.com/content/article/PII:S107476130000008X?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S107476130000008X?httpAccept=text/plain; https://linkinghub.elsevier.com/retrieve/pii/S107476130000008X; http://dx.doi.org/10.1016/s1074-7613%2800%2900008-x; https://dx.doi.org/10.1016/s1074-7613%2800%2900008-x; https://www.cell.com/immunity/fulltext/S1074-7613(00)00008-X; http://www.cell.com/article/S107476130000008X/abstract; http://www.cell.com/article/S107476130000008X/fulltext; http://www.cell.com/article/S107476130000008X/pdf; https://www.cell.com/immunity/abstract/S1074-7613(00)00008-X
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know